Enrofloxacin Base and Enrofloxacin HCl are widely recognized as cornerstone active pharmaceutical ingredients (APIs) within the veterinary medicine sector. These compounds are potent synthetic chemotherapeutic antimicrobial agents belonging to the fluoroquinolone class. Their broad-spectrum activity against a range of Gram-negative and Gram-positive bacteria, as well as mycoplasmas, makes them indispensable in treating bacterial infections in animals.

Typically presented as a light-yellow or light-yellow orange crystalline powder, Enrofloxacin Base and Enrofloxacin HCl boast high purity, essential for their efficacy and stability in final drug formulations. The quality of these APIs is paramount, and they are manufactured according to stringent standards, including GMP (Good Manufacturing Practice), ensuring consistency and reliability. Compliance with major pharmacopoeias such as BP, USP, EP, and CPV further underscores their quality credentials.

Detailed analysis confirms the superior quality of this raw material. A typical Certificate of Analysis for Enrofloxacin Base demonstrates key characteristics like a precise melting range (typically between 221°C and 226°C), meeting identification requirements, and exhibiting very low levels of related substances. Specifically, impurities like Fluoroquinolonic acid are controlled to be not more than 0.2%, and Ciprofloxacin content is kept minimal, often below 1.0%, such as 0.15%. The assay on a dried basis consistently shows a high purity, typically not less than 98.5% and often achieving 99.1% or higher. Parameters such as loss on drying (not more than 3.0%, typically 0.1%), residue on ignition (not more than 0.2%, typically 0.04%), and heavy metals (not more than 20ppm) are tightly controlled, guaranteeing a clean and effective API for veterinary drug production.

The primary application of Enrofloxacin Base and HCl is in the formulation of veterinary pharmaceuticals designed to combat bacterial diseases in livestock and poultry. They are effective in treating conditions affecting the respiratory, gastrointestinal, and urinary tracts, as well as skin and soft tissue infections. Examples from specific uses include antibacterial treatment for poultry and pigeon medicine, highlighting their utility across different species and infection types. The soluble powder form is particularly popular for ease of administration via drinking water or feed.

The importance of sourcing a high-quality Enrofloxacin Base powder cannot be overstated. The API's purity and physical properties directly impact the performance, safety, and shelf life of the final veterinary drug product. Choosing a raw material that meets rigorous standards ensures predictable therapeutic outcomes and supports regulatory compliance for the finished formulation.

Proper storage is crucial to maintain the integrity of Enrofloxacin Base. It should be kept in a light-proof, well-closed, dry, and cool place. Adhering to these storage conditions helps preserve its potency and extend its shelf life, which is typically around 3 years.

When considering the purchase of high-quality veterinary APIs like Enrofloxacin Base, sourcing from a reputable manufacturer is crucial. Factors such as production capacity, quality control processes, and regulatory compliance significantly influence the reliability of the supply chain. The competitive price for Enrofloxacin Base powder is often determined by bulk order quantities and prevailing market conditions, but compromising on quality for a lower upfront price can lead to significant issues in downstream manufacturing and product performance. Finding a reliable supplier who can offer detailed technical support and consistent product batches is key for pharmaceutical companies. Exploring options to buy Enrofloxacin Base involves evaluating various vendors based on their track record and ability to meet specific formulation needs. A transparent supplier will provide comprehensive documentation, including GMP certificates and Certificates of Analysis, ensuring traceability and compliance. Researching the market for the optimal buy strategy involves understanding global supply trends and production capacities of major manufacturers. Ultimately, securing a high-quality product at a competitive price from a trusted supplier ensures the success of veterinary pharmaceutical production.